{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:05:22Z","timestamp":1768583122123,"version":"3.49.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>The use of heparin during mechanical thrombectomy (MT) for acute large vessel occlusion ischemic stroke (LVO-AIS) is controversial, with no unified standard on its administration methods and efficacy. This study aims to investigate the effectiveness and safety of continuous intra-arterial infusion of heparin administration during MT in real-world practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A single-center retrospective study included consecutive LVO stroke patients treated with mechanical thrombectomy at Chongqing University Central Hospital (August 2022\u2013January 2024). Participants were stratified by intraprocedural heparin administration: (1) arterial heparin Group-continuous intra-arterial heparinization via high-pressure infusion (Heparin 1,000 IU was diluted in 500 ml of 0.9% sodium chloride solution and connected to both the guiding catheter and the intermediate catheter. The infusion bag was replaced as needed according to the duration of the procedure) at a conventional drip rate; (2) non-additional heparin Group-standard heparin solution flushing withoutusing additional anticoagulant. The main outcome were 3-months functional independence, defined as a modified Rankin Scale (mRS) \u2264 2. The main Safety outcome were defined as symptomatic intracranial hemorrhage (sICH) in 24 h.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 98 patients were eligible for analysis: 54 in the Arterial heparin Group and 44 in the Non-additional heparin Group. Continuous intra-arterial infusion of heparin administration during MT had a higher rates of functional independence (57.4 vs. 36.4%, adjusted\n                      <jats:italic>P<\/jats:italic>\n                      = 0.035), no significant impact on recanalization rate, sICH, distal embolization, or mortality (adjusted\n                      <jats:italic>P<\/jats:italic>\n                      &amp;gt; 0.05). However, the admission NIHSS score [odds ratio 1.225 (1.096\u20131.370),\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.01] was identified as independent predictor of unfavorable outcomes, while anticoagulant therapy during hospitalization [odds ratio 0.209 (0.067\u20130.653),\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.01] was a protective factor. Aspiration was a protective factor against sICH [odds ratio 0.009 (0.00\u20130.845),\n                      <jats:italic>P<\/jats:italic>\n                      = 0.042].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study suggests that continuous intra-arterial infusion of heparin administration during mechanical thrombectomy for acute large vessel occlusion ischemic stroke may be safe and is associated with higher rates of favorable outcomes. Further prospective research is needed to validate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1736654","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:22:48Z","timestamp":1768540968000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of continuous intra-arterial infusion of heparin administration in mechanical thrombectomy for acute ischemic stroke: a single-center retrospective study"],"prefix":"10.3389","volume":"16","author":[{"given":"Tao","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Neurology, Chongqing University Central Hospital","place":["Chongqing, China"]},{"name":"Chongqing Key Laboratory of Emergency Medicine","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chongqing University Central Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chongqing University Central Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chongqing University Central Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chongqing University Central Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chongqing University Central Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueqin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chongqing University Central Hospital","place":["Chongqing, China"]},{"name":"Chongqing Key Laboratory of Emergency Medicine","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1212\/WNL.0b013e31826959af","article-title":"Periprocedural antithrombotic strategies in acute ischemic stroke interventional therapy","volume":"79","author":"Nahab","year":"2012","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/neurintsurg-2017-013441","article-title":"Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial","volume":"10","author":"Winningham","year":"2018","journal-title":"J Neurointerv Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.04.009","article-title":"Safety of periprocedural heparin in acute ischemic stroke endovascular therapy: the multi MERCI trial","volume":"21","author":"Nahab","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s42155-025-00532-3","article-title":"The variable use of heparin through intravenous bolus and flush fluid systems during endovascular stroke treatment, a world-wide survey","volume":"8","author":"Frol","year":"2025","journal-title":"CVIR Endovasc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clineuro.2016.04.003","article-title":"Role of heparin during endovascular therapy for acute ischemic stroke","volume":"145","author":"Farook","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"108560","DOI":"10.1016\/j.clineuro.2024.108560","article-title":"Reevaluating the role of heparin during mechanical thrombectomy for acute ischemic stroke: increased risks without functional benefit","volume":"246","author":"Jazayeri","year":"2024","journal-title":"Clin Neurol Neuro Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1136\/jnis-2023-020551","article-title":"Periprocedural unfractionated heparin bolus during endovascular treatment in acute ischemic stroke does more harm than good","volume":"16","author":"Wischmann","year":"2024","journal-title":"J Neurointerv Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3171\/2024.1.JNS232584","article-title":"Periprocedural intravenous heparin in patients with acute ischemic stroke treated with endovascular thrombectomy after intravenous thrombolysis","volume":"141","author":"Wang","year":"2024","journal-title":"J Neurosurg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/jamaneurol.2025.2794","article-title":"Intravenous argatroban or eptifibatide in patients undergoing mechanical thrombectomy: a subgroup analysis of the MOST randomized clinical trial","volume":"82","author":"Rines","year":"2025","journal-title":"JAMA Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12883-015-0442-x","article-title":"Successful recanalization post endovascular therapy is associated with a decreased risk of intracranial haemorrhage: a retrospective study","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e007804","DOI":"10.1161\/JAHA.117.007804","article-title":"Downstream microvascular thrombosis in cortical venules is an early response to proximal cerebral arterial occlusion","volume":"7","author":"Desilles","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13244-025-02095-2","article-title":"White matter lesion effect modification of aspirin and unfractionated heparin during endovascular stroke treatment","volume":"16","author":"van Poppel","year":"2025","journal-title":"Insights Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism","volume":"29","author":"del Zoppo","year":"1998","journal-title":"Stroke"},{"key":"B15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fneur.2019.00299","article-title":"Safety and efficacy of heparinization during mechanical thrombectomy in acute ischemic stroke","volume":"10","author":"Yang","year":"2019","journal-title":"Front Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.12.022","article-title":"The risk of intracranial hemorrhage in japanese patients with acute large vessel occlusion; subanalysis of the RESCUE-Japan registry","volume":"25","author":"Enomoto","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1212793","article-title":"A trial of imaging selection and endovascular treatment for ischemic stroke","volume":"368","author":"Kidwell","year":"2013","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00062-018-0679-z","article-title":"Posterior circulation occlusions may be associated with distal emboli during thrombectomy: factors for distal embolization and a review of the literature","volume":"29","author":"Yeo","year":"2019","journal-title":"Clin Neuroradiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation","volume":"388","author":"Fischer","year":"2023","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1736654\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:22:49Z","timestamp":1768540969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1736654\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":20,"alternative-id":["10.3389\/fneur.2025.1736654"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1736654","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"article-number":"1736654"}}